Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
HDAC11 suppresses the thermogenic program of adipose tissue via BRD2
Rushita A. Bagchi, … , Edward Seto, Timothy A. McKinsey
Rushita A. Bagchi, … , Edward Seto, Timothy A. McKinsey
Published August 9, 2018
Citation Information: JCI Insight. 2018;3(15):e120159. https://doi.org/10.1172/jci.insight.120159.
View: Text | PDF
Research Article Metabolism

HDAC11 suppresses the thermogenic program of adipose tissue via BRD2

  • Text
  • PDF
Abstract

Little is known about the biological function of histone deacetylase 11 (HDAC11), which is the lone class IV HDAC. Here, we demonstrate that deletion of HDAC11 in mice stimulates brown adipose tissue (BAT) formation and beiging of white adipose tissue (WAT). Consequently, HDAC11-deficient mice exhibit enhanced thermogenic potential and, in response to high-fat feeding, attenuated obesity, improved insulin sensitivity, and reduced hepatic steatosis. Ex vivo and cell-based assays revealed that HDAC11 catalytic activity suppresses the BAT transcriptional program, in both the basal state and in response to β-adrenergic receptor signaling, through a mechanism that is dependent on physical association with BRD2, a bromodomain and extraterminal (BET) acetyl-histone-binding protein. These findings define an epigenetic pathway for the regulation of energy homeostasis and suggest the potential for HDAC11-selective inhibitors for the treatment of obesity and diabetes.

Authors

Rushita A. Bagchi, Bradley S. Ferguson, Matthew S. Stratton, Tianjing Hu, Maria A. Cavasin, Lei Sun, Ying-Hsi Lin, Dianxin Liu, Pilar Londono, Kunhua Song, Maria F. Pino, Lauren M. Sparks, Steven R. Smith, Philipp E. Scherer, Sheila Collins, Edward Seto, Timothy A. McKinsey

×

Figure 7

Mapping of HDAC11:BRD2 association domains.

Options: View larger image (or click on image) Download as PowerPoint
Mapping of HDAC11:BRD2 association domains.
(A) Schematic representation...
(A) Schematic representation of human HDAC11 and carboxy terminal deletion constructs. (B) Schematic representation of the HDAC11:BRD2 co-IP assay with HDAC11 deletion constructs. (C) Immunoblot assessment of endogenous BRD2 coimmunoprecipitating (co-IPed) with ectopic HDAC11. Total amounts of HDAC11 and BRD2 in protein homogenates were also determined (Input). (D) Schematic representation of human BRD2 and a carboxy terminal deletion construct. BD1, bromodomain 1; BD2, bromodomain 2; ET, extraterminal domain. (E) Schematic representation of the HDAC11:BRD2 co-IP assay with ectopic HDAC11 and ectopic BRD2. (F) Immunoblot assessment of ectopic BRD2 co-immunoprecipitating with ectopic HDAC11. Total amounts of epitope-tagged HDAC11 and BRD2 in protein homogenates were also determined (Input).

Copyright © 2025 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts